Overview

Rejuve.AI is a decentralized longevity research network that rewards ordinary people for contributing health data and AI models toward the science of extending healthy human lifespan. Founded in 2021 as a spin-off of SingularityNET — the decentralized-AI project led by Dr. Ben Goertzel — it sits at the intersection of decentralized science and artificial general intelligence. Where a classical longevity BioDAO funds drug programs through IP-NFTs, Rejuve pursues a different lever: pool the everyday health signals of a global membership, feed them to longevity-focused AI, and share the resulting value back with the people who supplied the data.

That makes Rejuve a clear example of a data-ownership DAO (a "data union") — the same archetype as genomic-data network GenomesDAO, but broadened from sequencing to the full stream of consumer health data (wearables, surveys, lab reports) and paired with an AI research engine. Its leadership team — CEO Jasmine Smith, CTO Dr. Deborah Duong, and Chief AI Scientist Dr. Ben Goertzel — ties the project directly into the SingularityNET and Cardano ecosystems.

The data-union model

Rejuve's core mechanism is an explicit two-sided exchange: contribute value to the network, receive RJV tokens in return. The network recognises two kinds of contribution — health data supplied through the app, and AI models supplied through the Global Collaboration Network (GCN). Members earn RJV by completing health surveys, uploading time-series data from wearables, joining focused data-gathering events, participating in Rejuve or partner-sponsored clinical trials, and referring others — and, crucially, by having their data actually used in a study or lead to new research or therapies.

This is the DeSci answer to the extractive Web2 health-data economy, where a platform monetises user data and keeps the upside. Rejuve inverts it: the contributor is the owner, consent and permissions are tracked on-chain, and the mission is to keep the resulting longevity insights affordable and accessible rather than locked behind a clinic paywall.

RJV token and the NFT layer

The RJV utility token launched in 2023, minted on both Ethereum and Cardano. It is the membership token of the Rejuve Network: it is earned by data and model contributors, and it is spent in the app's Rewards Store for discounts on wearables, medical tests, consultations, longevity therapies, and supplements — closing the loop so that the token's utility is health, not speculation.

Two NFT types sit alongside RJV to encode ownership rather than transactions:

• Data NFT — a unique NFT minted per member and linked to their RejuveID, which records and manages the permissions attached to that member's data.
• Product NFT — a fractionalized NFT allocated across everyone who contributed the data or effort behind a given product, so that downstream commercial value flows back proportionally to contributors.

The fractionalized Product NFT is the structural echo of the IP-NFT model pioneered by Molecule and VitaDAO, applied to data contributions instead of a single research program.

The AI research engine

What separates Rejuve from a pure data cooperative is the AI it feeds. The network's models are built on SingularityNET's AGI stack, including the OpenCog Hyperon framework. Rejuve's stated aim is not to fit surface correlations but to build mechanistic, dynamic models of human biology — combining neural nets, Bayesian networks, and simulation. Two named architectures anchor the current suite: BayesExpert, a probabilistic reasoning engine, and a Modular Transformer VAE neural network, together intended to produce a simulated model of a member's body with tailored, personalised longevity insights.

This AGI-adjacent ambition — treating aging as a systems-modelling problem — is what places Rejuve at the frontier where DeSci meets decentralized AI, and distinguishes it from BioDAOs whose value is a therapeutic pipeline rather than a model.

The Longevity app

Rejuve's consumer front door is the Rejuve Longevity mobile app, released on iOS on 31 March 2025 and on Android after a 4,000-person beta. It lets a global audience monitor health metrics, connect wearables, receive personalised insights, and accumulate RJV along the way — the on-ramp that turns the data-union thesis into a product ordinary people can actually use. Coverage at launch framed it as an attempt to give fairer access to longevity advice and treatments, with crypto rewards as the incentive to contribute; the app calculates its recommendations from over 370 biomarkers, more than 300 of them fed into the AI, and CEO Jasmine Smith pitched the point as much political as technical — “that progress shouldn't be gatekept.”

Governance and structure

Rejuve is best understood as a decentralized network with a token-membership economy inside the SingularityNET ecosystem, rather than an on-chain token-voting DAO in the Governor/Snapshot mould. RJV signifies membership and participation, and the NFT layer distributes ownership of data and product value; the network's direction is steered through the SingularityNET orbit and the Rejuve team rather than a formal proposal-and-vote treasury. In the DeSci landscape it is a reminder that "decentralization" spans a spectrum — from full on-chain governance to member-owned data cooperatives — and that the value being decentralized here is data and its upside, not just a treasury vote.

The 2026 turn: from research network to product line

Through 2026 Rejuve moved the emphasis from the data union to things a member can buy. In a post titled "Rejuve's Next Evolution: From Research Network to Longevity Intelligence Layer" the team recast the network around the model rather than the membership, and two concrete products followed.

• The Rejuve Longevity Journal (8 May 2026). A guided 90-day paper journal, described as the first product from "Rejuve Collective", bundled with a year of the forthcoming Pro tier. The post commits 7% of journal revenue to $RJV buybacks "in line with the community-supported buyback initiative" — a revenue-to-token link of the kind discussed at fee switches and value accrual, and one worth reading as a stated policy rather than an enforced one, since nothing in the token contract compels it.
• Rejuve Longevity Pro (27 May 2026). A roadmap update put a subscription tier at $11.99/month with a Q3 2026 target, the free tier retained, and named a v1.5.7 release as the engineering step toward it.

The shipping record is a useful check on the roadmap. The App Store still lists version 1.5.6, last updated 27 May 2026, read on 31 August 2026 — so the version the May roadmap named as the next step had not appeared three months later, and the Pro tier's Q3 target is unconfirmed on any first-party surface. Publication continues regardless: the newest post on the Rejuve blog is "Beyond Biomarkers: How the Exposome Is Changing Longevity Science", 7 August 2026.

The direction is worth noting for the DeSci reader beyond Rejuve itself: a data union whose members were promised token rewards for contributing has added a tier where members pay cash for insight. Both flows can coexist, but they point the incentive in opposite directions, and which one dominates is the question to keep asking of any data-ownership project that also sells a consumer product.

References

• Rejuve.AI — official site
• Rejuve.AI — Tokens (RJV, Data NFT, Product NFT, earning methods)
• Rejuve.AI — Longevity app
• SingularityNET — Rejuve.AI ecosystem profile
• Ben Goertzel — Rejuve Network Token Launch (SingularityNET, 2023)
• Rejuve Longevity app launch announcement
• Apple App Store — Rejuve.AI Longevity (release date 31 March 2025; v1.5.6, 27 May 2026)
• AgeTech World — AI-powered app to provide fairer access to longevity advice and treatments (3 April 2025)
• TechInformed — interview with CEO Jasmine Smith
• Cardano Developer Portal — Rejuve.AI feature